RSS   Newsletter   Contact   Advertise with us
Post Online Media

ProclaRx expands board of directors with new appointment

ProclaRxProclaRx, a biopharmaceutical company, announces the appointment of Dinar Dhond to its board of directors.
Article continues below

READ MORE Anthera appoints Brian R. Mueller to board

Mr. Dhond joins ProclaRx’s Board of Directors with over 30 years of professional experience in the healthcare and pharmaceutical industries.

Mr. Dhond currently serves as President of Nexus Informatics and is a founding member of Clinical Consulting Services, LLC, which includes Nexus Informatics, a software development company focused on developing patient access programs for specialty drugs; CSSi LifeSciences, a trusted partner from discovery to commercialization for developing drugs and devices; and CSSi, the global leader in patient recruitment, enrollment, and retention solutions for the clinical research industry.

Over the years, Mr. Dhond has held several senior level positions with companies such as Pharmaceutical Research Plus, Inc., Oracle Corporation, and HealthSTAR Communications, Inc.

Mr. Dhond holds a B.S. degree in Computer Science and an M.B.A from Loyola University Maryland.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy